85-2071-79　［受注停止］BRD2 Inhibitor II, BIC1 (BRD2 Bromodomain-Interactive Compound, BIC1, 1-(2-(1H-Benzimidazol-2-ylsulfanyl)ethyl)-3-methyl-1,3-dihydro-2H-benzimidazole-2-thione, 1-(2-(1H-Benzo[d]imidazol-2-ylthio)ethyl)-3-methyl-1H-benzo[d]imidazole-2(3H)-thione) 10mg　217230

特徴

• A cell-permeable benzimidazolyl-benzimidazolothione compound that directly interacts with BRD2-BD1 bromodomain reversibly (=28uM) and blocks the transcriptional activity of BRD2 in COS7 cells expressing Histac-K12 (<10uM). Shown to selectively disrupt BRD2 bromodomain-acetylated histone H4K12 association without modulating H4K12 acetylation; only weakly affect the interaction between the BRDT bromodomain (testis-specific bromodomain-containing protein) and acetylated histone H4.
• Formula:C17H16N4S2
• Molecular Weight:340.5
• Solubility:DMSO (50mg/ml)
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：10mg
• Grade：Highly Purified
• Purity：~95% (HPLC)
• Form：Supplied as an off-white solid.
• Molecular Formula：C17H16N4S2
• Molecular Weight Non Ab：340.5
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]